This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université De Versailles—saint-Quentin-En-Yvelines, Université Pierre Et Marie Curie (Paris 6). Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018
Title: Christophe Helary: Innovator in Tissue Repair Technologies
Introduction
Christophe Helary is an accomplished inventor based in Champigny sur Marne, France. He is recognized for his contributions to the field of biomedical engineering, particularly in developing innovative solutions for tissue repair. With a focus on collagen-based materials, Helary's work has significant implications in medical science, particularly in regenerative medicine.
Latest Patents
Christophe Helary holds a patent titled "Dense fibrillar collagen matrices for tissue repair and the preparation method thereof." This patent describes a method for preparing a homogeneous collagen-based material by concentrating a collagen solution. The process involves bringing the collagen solution into contact through continuous injection, ultimately creating a material that is effective for tissue repair.
Career Highlights
Helary's career includes noteworthy tenures at prestigious institutions, including the Université Pierre et Marie Curie (Paris 6) and the Centre National de la Recherche Scientifique. His work at these organizations has allowed him to break new ground in research and development, particularly in the realm of biomaterials.
Collaborations
Throughout his career, Christophe Helary has collaborated with several esteemed professionals, including Marie-Madeleine Giraud-Guille and Nadine Nassif. These collaborations have contributed to the advancement of his projects and have fostered innovations in tissue engineering.
Conclusion
Christophe Helary's innovative spirit and dedication to improving tissue repair technologies are evident through his patent and collaborative efforts. As a key figure in biomedical research, he continues to pave the way for advancements that could significantly enhance regenerative medicine practices in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile